Good MorningEquity markets rebounded on Wednesday, closing near the week's open after the CPI report came in as expected. As expected, inflation remains sticky, with headline consumer prices accelerating compared to the previous month and the core reading flat and at levels well above the Fed's target.
In this scenario, one of the Fed's mandates is covered - the labor market - and the other needs attention. This means the Fed may pause its rate-cutting cycle next week, contrary to the market's belief. The CME FedWatch Tool is pricing a nearly 100% chance for a 25 basis point rate cut.
Thursday's hurdle is the PPI index. The PPI is a leading indicator of inflation and will give a clue as to what to expect from the CPI next month. If it comes in hotter than expected, it could reinvigorate fear of the Fed and what higher-for-longer interest rates will do for the economy. Even if the FOMC cuts next week, it is highly unlikely that rates will be reduced further in 2025 without improvement in the data. Featured: WARNING: “Buffett Indicator” flashing for first time in 50 years (Behind the Markets) 
|
Markets | | |
It’s now the end of the investing year. As is customary, the biggest investment banks in the industry are starting to come out and issue their views for 2025. It is sort of the Super Bowl for the finance sector, where economists, strategists, and even quants come together to put forth the be... Read the Full Story |
|
From Our PartnersDid you miss out on the 1000%+ gains of Bitcoin over the past 5 years?
If so, you don't want to miss this... | | | | Watch this short video |
|
Markets | | | U.S. stock indexes fell Thursday following some potentially discouraging data on the economy. The S&P 500 slipped 0.5% for its fourth loss in the last six days. It’s a pause for the index, which has been rallying toward one of its best years of the millennium.The Dow Jones Industrial Average lo... Read the Full Story |
|
Markets | | |
The end of a year is a time for rebalancing portfolios. Part of that process is analyzing what worked well in the current year and where your investment thesis may need to change in the new year.
Several factors suggest the market could deliver strong results in 2025. Lower corporate ... Read the Full Story |
|
|
Markets | | | The European Central Bank is cutting interest rates by a quarter percentage point amid signs of weakening growth and concern about the impact of political chaos in France and the possibility of new U.S. import tariffs Read the Full Story |
|
Markets | | | The premier of Canada's most populous province said Wednesday he will cut off energy to the United States if President-elect Donald Trump imposes sweeping tariffs on all Canadian products. Trump has threatened to impose a 25% tax on all products entering the U.S. from Canada and Mexico unless they s... Read the Full Story |
|
|
Markets | | |
GameStop (NYSE: GME) shares edged higher following its Q3 release, but so what? The report included a surprise profit, but the underlying cause and business metrics align with the trend. This company continues to contract and is consuming itself at investors' expense. It only profited in Q3 becaus... Read the Full Story |
|
Markets | | | Embattled Japanese automaker Nissan has tapped Jeremie Papin, who was overseeing its U.S. operations, as its chief financial officer in a major management reshuffle billed as key to a turnaround.The move as announced in the United States on Thursday. It means Papin, chairman of Nissan’s Americas Man... Read the Full Story |
|
Markets | | |
The central processing unit (CPU) market is a cornerstone of the global technology sector, and it has long witnessed an intense rivalry between two industry titans: Advanced Micro Devices (NASDAQ: AMD) and Intel (NASDAQ: INTC).
For decades, these companies have competed fiercely to pro... Read the Full Story |
|
Markets | | | A lawyer and investor who managed money for one of the richest families in Texas, helped create one of the giants of the private-equity business and pushed to bring professional hockey to Seattle has died Read the Full Story |
|
Markets | | |
Robotic surgery used to be fodder for science fiction movies. Not anymore. They are becoming more mainstream by the day. While fully autonomous surgeries in the medical sector are not yet a reality, the field is evolving quickly. Currently, robotics are being used to augment the surgeon’s ab... Read the Full Story |
|
Thursday's Early Bird Stock Of The Day Enveric Biosciences, Inc., a biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders. Its lead product candidates are EB-002, an active metabolite of psilocybin, which is in preclinical development stage for the treatment of anxiety disorders; and EB-003 that is in preclinical development stage for the treatment mental health. The company also focuses on the development of cannabinoid conjugate molecules for the treatment of pain and cancer. Enveric Biosciences, Inc. is headquartered in Naples, Florida. | | View Today's Stock Pick |
|
